Investors
Information Disclosure
-
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER, 20222023.03.31
-
VOLUNTARY ANNOUNCEMENT - F-STAR ENTERED INTO LICENCE AGREEMENT WITH TAKEDA2023.03.22
-
NEXT DAY DISCLOSURE RETURN2023.03.20
-
VOLUNTARY ANNOUNCEMENT - COMPLETION OF ACQUISITION OF F-STAR THERAPEUTICS, INC.2023.03.09
-
NOTIFICATION OF BOARD MEETING2023.03.03
-
VOLUNTARY ANNOUNCEMENT - BEVACIZUMAB INJECTION APPROVED FOR MARKETING2023.03.03
-
VOLUNTARY ANNOUNCEMENT - THREE PRODUCTS APPROVED FOR MARKETING2023.03.01
-
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 20232023.03.01